Literature DB >> 8217101

Mechanism of bone turnover.

H K Väänänen1.   

Abstract

Bone remodelling is a cellular mechanism behind the bone turnover. It renews the old bone piece by piece and thus ensures the correction of possible microdamage and enables the regulation of mineral homeostasis. The basic mechanism of bone remodelling is similar in all types of bone and includes the resorption of old bone and the formation of equal amount of new bone at the same place. Histomorphometric studies have revealed the cellular details of remodelling and have shown that it is composed by the temporally and spatially regulated action of different bone cells and their precursors. Recent in vitro studies with osteoclasts and osteoblasts have increased our knowledge of the molecular mechanisms of bone remodelling. Molecular characterization of bone matrix proteins have suggested new functions to many of them and thereby increased our possibilities of understanding the local regulation mechanisms of remodelling. Bone matrix has been shown to contain several biologically active compounds which have effects on bone forming and resorbing cells and their precursors. Details of the functional mechanism of osteoclasts are also in the process of being discovered. However, several questions concerning bone remodelling still remain open: the molecular explanation for selection of the remodelling site; the coupling of bone resorption to formation, and the interactions between different cell types during the remodelling cycle.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8217101     DOI: 10.3109/07853899309147297

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  8 in total

1.  A 4 bp deletion mutation in DLX3 enhances osteoblastic differentiation and bone formation in vitro.

Authors:  Sun Jin Choi; In Sun Song; Ok Hee Ryu; Sung Won Choi; P Suzanne Hart; Wells W Wu; Rong-Fong Shen; Thomas C Hart
Journal:  Bone       Date:  2007-09-19       Impact factor: 4.398

Review 2.  Molecular aspects of osteoclast function.

Authors:  T J Hall; T J Chambers
Journal:  Inflamm Res       Date:  1996-01       Impact factor: 4.575

3.  Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood.

Authors:  Mette Grøndahl Sørensen; Kim Henriksen; Sophie Schaller; Dennis Bang Henriksen; Finn Cilius Nielsen; Morten Hanefeld Dziegiel; Morten Asser Karsdal
Journal:  J Bone Miner Metab       Date:  2007-01-01       Impact factor: 2.626

4.  Quantitative immunodetection of key elements of polyphosphoinositide signal transduction in osteoblasts from arthritic patients shows a direct correlation with cell proliferation.

Authors:  Nicoletta Zini; Gina Lisignoli; Liliana Solimando; Alberto Bavelloni; Aurelio Valmori; Sandra Cristino; Alberto Maria Martelli; Andrea Facchini; Nadir Mario Maraldi
Journal:  Histochem Cell Biol       Date:  2005-09-29       Impact factor: 4.304

5.  The effects of bisphosphonates on the resorption cycle of isolated osteoclasts.

Authors:  K Selander; P Lehenkari; H K Väänänen
Journal:  Calcif Tissue Int       Date:  1994-11       Impact factor: 4.333

6.  Connexin-mimetic peptide Gap 27 decreases osteoclastic activity.

Authors:  J Ilvesaro; P Tavi; J Tuukkanen
Journal:  BMC Musculoskelet Disord       Date:  2001-12-05       Impact factor: 2.362

Review 7.  Modulation of Osteoclast Interactions with Orthopaedic Biomaterials.

Authors:  Chris Steffi; Zhilong Shi; Chee Hoe Kong; Wilson Wang
Journal:  J Funct Biomater       Date:  2018-02-26

8.  Protocatechuic Acid Attenuates Trabecular Bone Loss in Ovariectomized Mice.

Authors:  Seon-A Jang; Hae Seong Song; Jeong Eun Kwon; Hyun Jin Baek; Hyun Jung Koo; Eun-Hwa Sohn; Sung Ryul Lee; Se Chan Kang
Journal:  Oxid Med Cell Longev       Date:  2018-07-29       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.